(Des-Gly10,D-His(Bzl)6,Pro-NHEt9)-LHRH acetate salt structure
|
Common Name | (Des-Gly10,D-His(Bzl)6,Pro-NHEt9)-LHRH acetate salt | ||
|---|---|---|---|---|
| CAS Number | 220810-26-4 | Molecular Weight | 1323.50 (free base) | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C66H86N18O12.xC2H4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (Des-Gly10,D-His(Bzl)6,Pro-NHEt9)-LHRH acetate saltHistrelin acetate, a GnRH analogue, is a GnRH Receptor agonist. Histrelin acetate increases serum luteinising hormone (LH), follicle stimulating hormone (FSH) and testosterone levels. Histrelin acetate can be used in the research of prostate cancer, endometriosis[1][2][5]. |
| Name | histrelin acetate |
|---|
| Description | Histrelin acetate, a GnRH analogue, is a GnRH Receptor agonist. Histrelin acetate increases serum luteinising hormone (LH), follicle stimulating hormone (FSH) and testosterone levels. Histrelin acetate can be used in the research of prostate cancer, endometriosis[1][2][5]. |
|---|---|
| Related Catalog | |
| References |
[1]. Emma D Deeks, et al. Histrelin: in advanced prostate cancer. Drugs. 2010 Mar 26;70(5):623-30. |
| Molecular Formula | C66H86N18O12.xC2H4O2 |
|---|---|
| Molecular Weight | 1323.50 (free base) |
| Exact Mass | 1442.71000 |
| PSA | 521.46000 |
| LogP | 3.97960 |
| InChIKey | OWAUGAMNPZHEOJ-YKZVIGSYSA-N |
| SMILES | CC(=O)O.CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(Cc1cn(Cc2ccccc2)cn1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1cnc[nH]1)NC(=O)C1CCC(=O)N1 |